Why Digital-First Research Platforms Are Replacing Site-Centric Trial Models

For decades, clinical research has been built around a simple assumption: research happens at sites; participants come to those sites, and data flows upward from there. That model worked when trials were smaller, slower, and geographically constrained. 

It is now actively holding research back. 

As trials scale across populations, geographies, and data sources, site-centric models are showing their limits. Recruitment delays, participant drop-off, fragmented data, rising operational costs, and mounting compliance pressure are no longer edge cases. They are the norms. 

What we are witnessing is not a tooling problem. It is a structural one. 

The Problem with Site-Centric Models at Scale

Even before we dreamt up hybrid and decentralized trials, the numbers were grim: 

• 85% of clinical trials fail to retain enough participants under traditional protocols. That’s not a “surprise” number — it’s systemic.
• Up to 50% of sites enroll one or zero participants in the studies they support.
• Recruitment alone can eat 40% of a sponsor’s entire clinical trial budget.
• One analysis found the typical trial spends nearly $900,000 on recruitment and retention, and delays can cost millions per day in lost sales. 

Those aren’t edge cases; they are the norm. Site visits, travel logistics, and rigid protocols haven’t just slowed research; they’ve constrained who can participate. An 2025 Guardian analysis pointed out that young adults are drastically underrepresented in traditional research, limiting the relevance and applicability of findings.  

Digital-first research platforms change the center of gravity

Digital-first research platforms invert the model. Instead of sites being the center of gravity, the platform becomes the foundation. Sites still matter, but they operate within a connected, participant-centric digital ecosystem. 

This shift unlocks several critical advantages. 

• Participants engage where they are, through mobile and web experiences designed for enrollment, onboarding, communication, and long-term participation. Geography stops being a bottleneck.
• Data is captured continuously and centrally, integrating inputs from wearables, sensors, mobile apps, and clinical systems into secure, analytics-ready environments.
• Operations move from coordination to orchestration, with automated workflows, dashboards, and reporting replacing spreadsheets and email chains.
• Retention becomes a design outcome, driven by thoughtful digital experiences, behavioral science, and consistent communication rather than manual follow-ups.
• Compliance is embedded, not layered at the end, with secure architectures, audit-ready reporting, and regulatory alignment built into the platform itself. 

The result is not just faster trials. It is a fundamentally different research capability.  

Why this shift is accelerating now

Several forces are converging to make digital-first research unavoidable: 

• Real-world evidence expectations are growing, requiring longitudinal, continuous data capture
• Decentralized and hybrid trial models are moving from pilot to mainstream
• AI and advanced analytics demand cleaner, integrated data foundations
• Public health and non-profit research must reach broader, more diverse populations
• Funding and regulatory scrutiny increasingly reward transparency and rigor 

Organizations that treat digital research as a collection of point solutions struggle to keep up. Those that invest in platforms scale with far less friction. 

Why Research Needs to Go Digital-First Now

Several forces are converging to make digital-first research unavoidable: 

• Real-world evidence expectations are growing, requiring longitudinal, continuous data capture
• Decentralized and hybrid trial models are moving from pilot to mainstream
• AI and advanced analytics demand cleaner, integrated data foundations
• Public health and non-profit research must reach broader, more diverse populations
• Funding and regulatory scrutiny increasingly reward transparency and rigor 

Organizations that treat digital research as a collection of point solutions struggle to keep up. Those that invest in platforms scale with far less friction. 

A Platform-First Approach to Modern Research Enablement

Radiant Digital approaches this shift with a simple principle: research scales when platforms are designed end-to-end, not stitched together over time. 

Through its Digital Health Research Enterprise (DHRE), Radiant Digital helps research organizations move beyond isolated digital tools toward a unified research foundation. The platform supports participant enrollment, engagement, and retention, alongside secure data capture, analytics, regulatory-ready reporting, and multi-supplier collaboration. 

This enables research hospitals, academic centers, public health agencies, and non-profits to run studies that are more participant-centric, operationally resilient, and data-driven. Several Radiant Digital case studies highlight our collaboration and partnership in Digital Health: explore here. 

Rather than digitizing individual tasks, Radiant Digital focuses on building research systems that are scalable by design, compliant by default, and adaptable to evolving study models.  

The Digital Shift Leaders Can’t Ignore

The shift toward digital-first research platforms isn’t hype. It’s evidence-driven, participant-validated, and increasingly endorsed by regulators and industry alike. 

Organizations that cling to site-centric models will find themselves outpaced by competitors embracing platforms that are scalable, inclusive, data-rich, and cost-effective. Those that act now will not just improve their next trial; they’ll build the capability to innovate quickly across portfolios. 

Before your next trial scales the old way, get a digital-first research roadmap from Radiant Digital’s DHRE experts and see what changes when platforms lead.  

Connect with us now at info@radiant.digital and www.radiant.digital